Content about Scimera BioScience

February 25, 2013

Scimera BioScience announced the launch of a novel probiotic formulation, Asprega ProPac, to address the gastrointestinal side effects of antibiotic therapy including antibiotic-associated diarrhea.

MIAMI — Scimera BioScience on Thursday announced the launch of a novel probiotic formulation, Asprega ProPac, to address the gastrointestinal side effects of antibiotic therapy including antibiotic-associated diarrhea. Unique to ProPac, Scimera packages its probiotic in a convenient 10-day course.